81% Of China’s Generic Drug Applications Are Redundant
This article was originally published in PharmAsia News
Chinese authorities received 2,095 generic registration applications in 2012, more than 81% of them are for generic versions of branded drugs that already have multiple approved generics.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.